Life-expectancy for individuals with younger-onset disease is on average of 16 years shorter compared to people without diabetes, and
Tag: Cardiovascular complications
Jynarque for treating kidney disease
FDA approves Jynarque (tolvaptan) to slow kidney function decline in rapidly progressing autosomal dominant polycystic kidney disease ADPKD. ADPKD is
